Synaffix secures additional ADC technology licensing deals
January 6th, 2023 | 🕒
iSpeech.org First off, it inked a licensing agreement with Amgen to develop next generation ADCs. Amgen will gain access to
Browsing the "synaffix" Tag
Synaffix Wins ‘Best ADC Platform Technology’ Award Again at World ADC Awards Ceremony 2022
September 15th, 2022 | 🕒
Text to Speech AMSTERDAM, Sept. 15, 2022 /PRNewswire/ -- Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology
Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal
September 6th, 2022 | 🕒
iSpeech.org Synaffix to provide access to proprietary ADC technologies (GlycoConnect™, HydraSpace™ and exatecan-based SYNtecan E™ linker-payload) Emergence Therapeutics secures rights
Genmab and Synaffix Enter into License Agreement for ADC Technology
January 4th, 2022 | 🕒
https://www.ispeech.org Media Release Synaffix to provide access to proprietary antibody-drug conjugate (ADC) technologies Genmab secures rights for conducting research on
Synaffix to Present Key ADC Technology Data on SYNtecan ETM Linker-Payload at World ADC Conference
October 13th, 2021 | 🕒
iSpeech Virtual poster presentation shows complete tumor regression and high tolerability of a SYNtecan E™ based ADC SYNtecan E™ linker-payload
Third ADC with Synaffix’s Technology Enters Clinical Development
September 29th, 2021 | 🕒
https://www.ispeech.org - Partner Shanghai Miracogen (fully owned by LEPU BIOPHARMA CO., LTD) commences US Phase I/II trial with ADC designed
Kyowa Kirin Taps Synaffix ADC Technology to Expand Its Pipeline
August 4th, 2021 | 🕒
Text to Speech TOKYO & AMSTERDAM--(BUSINESS WIRE)--Kyowa Kirin Co., Ltd. (TSE:4151, President and CEO: Masashi Miyamoto, ”Kyowa Kirin”), a global
Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
June 29th, 2021 | 🕒
https://www.ispeech.org/text.to.speech SAN FRANCISCO and SUZHOU, China, June 28, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company
-
Donate Via Wallets
-
MetaMask -
Trust Wallet -
Binance Wallet -
WalletConnect
-
-
Popular
Debian Security Advisory 5664-1 – Torchsec April 18, 2024 -----BEGIN PGP SIGNED MESSAGE-----Hash: SHA512- -------------------------------------------------------------------------Debian Security Advisory DSA-5664-1 security@debian.orghttps://www.debian.org/security/… (10)
Hackers Exploiting WP-Automatic Plugin Bug to Create… April 26, 2024 Apr 26, 2024NewsroomThreat Intelligence / Cyber Attack Threat actors are… (9)- AnyDesk 7.0.15 Unquoted Service Path – Torchsec April 9, 2024 # Exploit Title: AnyDesk 7.0.15 - Unquoted Service Path PrivilegeEscalation#… (8)
- Red Hat Security Advisory 2024-1687-03 – Torchsec April 9, 2024 The following advisory data is extracted from:https://access.redhat.com/security/data/csaf/v2/advisories/2024/rhsa-2024_1687.jsonRed Hat officially shut… (8)
👥Members
-
🌍 Forum Groups
-
linktr.ee/obewyn
Gloss